Efficacy and safety of S-1 based adjuvant chemoradiotherapy for resected pancreatic ductal adenocarcinoma with high-risk pathological feature: a prospective, single-arm, interventional study

Efficacy and safety of S-1 based adjuvant chemoradiotherapy for resected pancreatic ductal adenocarcinoma with high-risk pathological feature: a prospective, single-arm, interventional study

Abstract. Objective:. It remains unclear whether adjuvant chemoradiotherapy (CRT) improves survival outcome of pancreatic ductal adenocarcinoma (PDAC) patients after surgery. This study aimed to investigate the efficacy and safety of tegafur/gimeracil/oteracil (S-1)-based adjuvant concurrent chemor...

Full description

Bibliographic Details
Main Authors: Lili Wu, Yaolin Xu, Zhaochong Zeng, Yixing Chen, Yuhong Zhou, Dansong Wang, Jing Sun, Minzhi Lv, Shisuo Du, Wenhui Lou
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2022-03-01
Series:Journal of Pancreatology
Online Access:http://journals.lww.com/10.1097/JP9.0000000000000084

Internet

http://journals.lww.com/10.1097/JP9.0000000000000084

Similar Items